Gerald Kay Estate Edward - 20 Mar 2023 Form 3 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role: 10%+ Owner
Signature: /s/ Christina Kay
Issuer symbol: INBP
Transactions as of: 20 Mar 2023
Net transactions value: $0
Form type: 3
Filing time: 16 Nov 2023, 13:49:12 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	INBP	Common Stock						3,293,815	20 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	INBP	Stock Option (right to buy)							20 Mar 2023	Common Stock	150,000	$0.2300	Direct	F2
holding	INBP	Stock Option (right to buy)							20 Mar 2023	Common Stock	66,667	$0.7200	Direct	F2
holding	INBP	Stock Option (right to buy)							20 Mar 2023	Common Stock	21,667	$1.04	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 819,628 shares currently registered in the name of EGK LLC, an entity Mr. E Gerald Kay was the sole member of.
F2	Acquired upon the passing of E Gerald Kay, the former President and Executive Chairman of the Issuer.